Clover Health is trading at $4.68, up 4.58%, after raising its 2026 outlook following strong third-quarter results.

  • Third-quarter revenue was $759.3 million, up 53% year over year.
  • Results included $6 million in quarterly GAAP net income; management expects full-year profitability.
  • Shares also rose alongside a broader market rebound, with the Nasdaq up 1.47% in the supplied market context. No reliable volume figure was confirmed.